ReviewBME frontiers2024
Making "CASES" for AI in Medicine.
Review in BME frontiers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Multimodal multi-instance learning for cardiopulmonary exercise testing performance prediction.NPJ digital medicine · 2026Article
- Urea-Formaldehyde Resin Confined Silicon Nanodots Composites: High-Performance and Ultralong Persistent Luminescence for Dynamic AI Information Encryption.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Drug pair-derived synergistic therapy of flavonoids luteolin and astragaloside IV promotes neural repair following spinal cord injury via antioxidant and neuroprotective effects.Precision clinical medicine · 2026Article
- AI-driven biomarker learning for the early diagnosis of neurodegenerative diseases: ABLEDx.Journal of nanobiotechnology · 2026Article
- Iron Oxide-Based Surface-Enhanced Raman Spectroscopy Bioprobes for Detecting Tumor Cells in Serous Effusion.Analytical chemistry · 2026Article
- Uridine inhibits ROS-mediated osteoclast differentiation and alleviates osteoporosis via modulation of PI3K/Akt-FoxO signaling.Frontiers in immunology · 2026Article
- Doping-Engineered Proangiogenic Nanozymes Orchestrate Ischemic Tissue Regeneration via Cytoprotection and Revascularization.Research (Washington, D.C.) · 2026Article
- Medical multimodal multitask foundation model for lung cancer screening.Nature communications · 2025Article
- Spatially Resolved Multiomics: Data Analysis from Monoomics to Multiomics.BME frontiers · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
In this perspective, "CASES" are made for AI in medicine. The CASES mean Confidence, Adaptability, Stability, Explainability, and Security of AI systems. We underline that these CASES can be addressed not only individually but also synergistically on the large model platform and using cutting-edge diffusion-type models.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.